Paula Cannon speaks at the 2011CIRM Grantee Meeting about a stem cell-based therapy for HIV/AIDS. Cannon is a co-principle investigator on a disease team that has the goal of engineering a person's own bone marrow to make the cells resistant to HIV. CIRM awarded a $14 million grant to support the program.
See the article here:
HIV/AIDS: Advancing Stem Cell Therapies: 2011 CIRM Grantee Meeting - Video